| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0008 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |